A screenshot of an iPad screen displaying an overview of XARTEMIS XR (Oxycodone HCI) and acetaminophen Extended-Release Tablets (CII). The screen is divided into two sections.
On the left side of the screen there is a title that reads "Fast onset of relief" and below it there are two bullet points that explain the results of the study. The first bullet point explains that the study was conducted in a clinical trial median time to confirmed onset of pain relief was 48 minutes. The second bullet point states that the primary endpoint XARTEMIS XR demonstrated a statistically significant improvement in the summed pain intensity difference to placebo (114.9 mg/ml) over 48 hours (SPD).
The third bullet point mentions the study's effectiveness study design and the importance of risk information. The fourth bullet point says "Medium Time to Confirmed Onset of Pain Relief". The fifth bullet point points states that there is an increase in the number of patients who have been diagnosed with pain relief.
At the bottom of the image there has a button that says "Important Risk Information" and a link to a website for more information.
Description 
Type
Category
Source 1 of 5
-
Date
2014
Collection
-
Date
2014
Collection
-
Date
2012
Collection
-
Date
2014
Collection
-
Date
2014
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.
